The letter detailed how Cigna and Anthem are claiming that “combining ASO plans presents relatively low antitrust risk, even in highly concentrated markets, because health plans merely ‘pass through’ provider costs to customers and, therefore, do not have the opportunity to earn a profit on them, or on the financial risk associated with the customers’ medical claims,” according to AHA Senior Vice President and General Counsel Melinda Reid Hatton, who wrote the letter.
However, the AHA argues that “[a]ny notion that ASO health insurance contracts are somehow immune from the standard principles of supply and demand is inconsistent with market realities, basic economics and common sense.”
Click here to read the letter in its entirety.
More articles on payer issues:
Bayhealth Medical Center, Highmark BCBS of Delaware in contract dispute
Health insurers in the news: April 14-21
Express Scripts denies claims, countersues Anthem
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
